73 results on '"P, Bourgeot"'
Search Results
52. Medico-economic Analysis of the Treatment of Abdominal Aortic Aneurysms
- Author
-
Abello, Nicolas, Chretien, Nicolas, Bourgeot, Caroline, Crespy, Valentin, Favier, Claire, Dominguez, Joaquin, and Steinmetz, Eric
- Published
- 2015
- Full Text
- View/download PDF
53. The Volume of the Thrombus Decreases the Incidence of Type 2 Endoleaks after EVAR
- Author
-
Chrétien, Nicolas, Bourgeot, Caroline, Crespy, Valentin, Abello, Nicolas, Favier, Claire, Dominguez, Joaquin, and Steinmetz, Eric
- Published
- 2015
- Full Text
- View/download PDF
54. High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies
- Author
-
Michallet, Mauricette, Sobh, Mohamad, Morisset, Stephane, Labussière-Wallet, Hélène, Detrait, Marie Y., Dubois, Valerie, Bourgeot, Jean-Paul, Ducastelle, Sophie, Barraco, Fiorenza, Chelghoum, Youcef, Mialou, Valerie, Chapelle, Valérie, Sar, Sothiny, Hequet, Olivier, Thomas, Xavier, Nicolini, Franck E., and Bertrand, Yves
- Abstract
Nicolini: Novartis, Bristol Myers-Squibb, Pfizer, ARIAD, and Teva: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding.
- Published
- 2012
- Full Text
- View/download PDF
55. Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.
- Author
-
Michallet, Mauricette, Le, Quoc-Hung, Thiebaut, Anne, Ducastelle, Sophie, Raus, Nicole, Revesz, Daniela, Troncy, Jacques, Chelgoum, Youcef, Bourgeot, Jean-Paul, Dubost, Philippe, Hequet, Olivier, and Nicolini, Franck E.
- Abstract
This study concerns the impact of infused PBSC parameters [total nucleated cells (TNC), CD34+ cells, CFU-GM and CD3+ cells] associated with the other pre-transplant variables on the transplant outcome after allogeneic reduced intensity conditioning hematopoietic stem cell transplantation (HSCT). There were 95 patients, 58 males and 37 females with a median age of 53 years (27–66.5). The diagnosis pre-transplant were 21 AML, 1 ALL, 8 CML or MPS, 10 CLL, 16 MDS, 9 NHL, 3 HD, 27 MM. The disease status pre-transplant were 29 CR, 38 PR, 10 stable disease (SD) and 18 progressive disease (PD) and we defined a low risk subgroup of 38 patients (40%) including all diseases in CR1 and MM in CR, PR1 or PR2. For conditioning, 31 patients received an association of Fludarabine and TBI, 54 Fludarabine, Busulfan and ATG (FBA) (ATG 2.5mg/kg:15, ATG 5mg/kg: 27, ATG 7.5–12.5mg/kg:12) and 10 received other associations. All patients received PBSC from 93 HLA identical sibling donors and 2 from 1 antigen HLA mismatched related donors with donor median age of 52 years (29–73). Fifty-eight patients were sex mismatched (F/M:36, M/F:22), for CMV status: 26 pairs were negative, 38 positive and 31 mismatched and 28 patients presented an incompatibility ABO Rhesus with their donors. The patients received a median number of TNC 9.41× 108/Kg (2.6–25), CD34+ cells 6×106/Kg (1.2–64), CD3+ cells 262 ×106/Kg (32.8–761) and CFU-GM of 127×104/Kg (12–470). After transplant, 41 patients developed an acute GVHD ≥ grade II (II: 16, III: 10 and IV: 15) and 39 patients a chronic GVHD (15 limited, 24 extensive). With a median follow-up of 24.5 months, 43 patients have relapsed and 37 are alive. The probability of OS and EFS at 3 years was 35.4% [26–48] and 23% [15–35] respectively and the TRM at 1 year 24%. The results of the multivariate analysis using a Cox proportional hazard model and a logistic regression stepwise procedure are shown in the table 1. In conclusion, this study shows a significant impact of recipient age, low risk disease, sex mismatching, FBA 2.5mg/kg, CMV status and TNC and demonstrates among the infused PBSC parameters the very important role of the CFU-GM number on transplant outcome after RICT. Table 1: Multivariate analysis OS EFS TRM AGVHD cGVHD Disease status pre-transplant, type of donor, type of conditioning, HLA matching, ABO matching: NS Recipient Age HR:1.09 (1.01–1.16) HR:1.19 (1.03–1.38) HR:0.91 (0.84–0.99) HR:0.91 (0.84–0.99) p=0.01 p=0.02 p=0.04 p=0.04 Sex Matching HR:0.16 (0.03–0.89) p=0.04 CMV Status HR:0.11 (0.01–0.9) HR:0.11 (0.01–0.9) p=0.04 p=0.04 Low risk Disease HR:0.13 (0.02–0.77) HR:0.02 (0.001–0.04) HR:0.02 (0.001–0.04) p=0.02 p=0.01 p=0.01 FBA 2.5mg/kg HR:6.46 (1.50–27.71) p=0.01 TNC HR:1.19 (1.06–1.35) p=0.03 CFU-GM HR:1 (0.98–1.14) HR:1.006 (1.002–1.01) HR:1.01 (1.001–1.02) HR:0.99 (0.98–1) p=0.03 p=0.004 p=0.02 p=0.05
- Published
- 2007
- Full Text
- View/download PDF
56. Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.
- Author
-
Michallet, Mauricette, Le, Quoc-Hung, Michallet, Anne-Sophie, Thiebaut, Anne, Tavernier, Emannuelle, Rafii, Hanadi, Revesz, Daniela, Troncy, Jacques, Praire, Aline, Gadolet, Elodie, Dubois, Valerie, Gebuhrer, Lucette, Hequet, Olivier, Bourgeot, Jean-Paul, and Nicolini, Franck E.
- Abstract
Management of donor lymphocyte infusions (DLI) after reduced intensity conditioning regimen allogeneic hematopoietic stem cell transplantation (RICT) remains not clear and needs prospective studies. We performed a retrospective analysis on 47 patients (29 males and 18 females) who received 94 DLI among 96 patients who underwent RICT in our institution. Twenty-four patients received 1 DLI (D) [mean dose: 0.3x108 CD3 /Kg (0.01–1)] and 70 escalating doses (ED) [2 DLI (n=10), 3 DLI (n=9), 4 DLI (n=1), 5 DLI (n=1), 6 DLI (n=1) and 8 DLI (n=1)] from 0.1 to 5.6x108 CD3/Kg. The diagnosis pretransplant was acute leukemias (n=10) and myelodysplasia (n=3), chronic myeloid leukemia (n=2), Hodgkin (n=7) and non Hodgkin lymphomas (n=6), multiple myeloma (n=14) and solid tumours (n=5). Twenty patients have already been transplanted before RICT and 9 patients were in complete remission (CR), 19 in partial response (PR), 18 in evolutive disease (EDis). As hematopoietic stem cells, 22 patients received peripheral blood and 25 bone marrow and as conditioning 26 patients received busulfan, fludarabine and anti-thymocytes globulines (ATG), 13 patients TBI 2 grays associated to fludarabine (n=8) and 6 grays associated with cyclophosphamide (n=5), 5 patients received cyclophosphamide and ATG and 3 patients aracytine, idarubicine and fludarabine. After transplant and before any DLI, 21 developped acute GVHD (11 grade I, 8 grade II and 2 grade III). The indications and results after DLI are given in the Table 1. Only 4 patients received DLI for two different indications within time: 2 for relapse firstly and partial chimerism secondly and 2 according to protocol requirement firstly and for relapse secondly. After DLI, we noted 18 acute GVHD (7 grade I, 4 grade II, 6 grade III and 1 grade IV), 9 were resolutive after specific therapy and 18 patients developed chronic GVHD (13 limited and 5 extensive). Probability of overall survival at 2 years of patients who underwent RICT including DLI (n=47) was significantly better than for patients undergoing RICT without DLI (n=57) [43% (95%CI 30.5–60.4) vs 31.5 (95%CI 18.8–52.8) (p=0.01)] but there was no difference when we consider EFS [20.7% (95%CI 11.6–36.8) vs 21.6% (11–42.5) (p=0.49)]. We performed for patients receiving DLI a multivariate analysis stratified on diagnosis studying sex, age, status at transplant and mean dose of infused lymphocytes and we demonstrated that lymphocyte dose had a significant negative impact on EFS (HR= 1.06 95% CI 1.01–1.10) (p=0.01). To better understand the real place of DLI within allogeneic immunotherapy against malignancies, we need more details about the results of DLI in retrospective analysis but principally prospective studies in the future. TABLE 1 Indication of DLI Nb of patients Nb of DLI DLI (D) DLI (ED) Dose x 10 exp8 CD3/Kg Response to DLI Evolutive Disease N = 34 23 2.26 10 13 1.46 EDis 5 1.6 2 3 0.66 CR 6 1.5 2 4 0.45 PR Mixed Chimerism N = 7 6 1.5 5 1 0.7 Total Donor 1 1 1 0 0.7 Mixed Chimerism Protocol N = 6 1 1 1 0 0.1 CR 3 1.6 2 1 0.34 PR 2 2 1 2 0.52 EDis
- Published
- 2004
- Full Text
- View/download PDF
57. B-Cell Depletion and Prevention of Hemolysis in Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO Incompatibility.
- Author
-
Tavernier, Emmanuelle, Thiebaut, Anne, Nicolini, Franck, Le, Quoc Hung, Thomas, Xavier, Chelghoum, Youcef, Revesz, Daniela, Hecquet, Olivier, Dubost, Philippe, Bourgeot, Jean-Paul, and Michallet, Mauricette
- Abstract
Immune hemolysis is a severe complication of allogeneic peripheral blood stem cell (PBSC) transplantation with minor ABO-incompatibility, principally observed after conventional allogeneic PBSCT. The B-cell depletion of the PBSC graft is a prophylactic intervention which may decrease incidence and severity of this event. Eight patients who underwent allogeneic PBSCT in our institution between August 1999 and April 2004 were analysed. They all received a B-cell depleted transplantation performed because of minor ABO-incompatibility. There were 5 males and 3 females and the median age was 42.5 years (19–65). The pre-transplant diagnosis were solid tumours for 2 patients and haematological malignancies for 6. All received allogeneic PBSC recruited by G-CSF from 3 HLA identical unrelated and 5 HLA identical sibling donors. The median number of nucleated cells and CD34+ cells harvested were 7.75x108 /Kg (3.9–11) and 6x106/kg (4.3–8.7) and the median number of infused cells were 5.5x108 /Kg (3.4–8.71) and 5x 106/kg (3.1–8.33) respectively. Two patients received myeloablative and 6 patients reduced intensity conditioning regimens (RIC). As graft-versus-host-disease (GVHD) prophylaxis, cyclosporin with methotrexate was given after myeloablative conditioning. After RIC, cyclosporin alone (n=4) or cyclosporin associated to methotrexate (n=1) or cyclosporin associated to mycophenolate mofetil (n=1) were given. The ex-vivo manipulation consisted of a negative CD19 immuno-selection using the Isolex 300 I Baxter procedure. The median number of CD19+ cells (x106/kg) before and after ex-vivo manipulation was respectively 73 and 0.05, which represented a B-cell log depletion of 3.16. The ex-vivo manipulation nevertheless induced a nucleated cell depletion of 20% (from 7.75 x108 cells/kg to 5.52x108 cells/kg after B-cell depletion) and a CD34+ cell loss of 18.5% (from 6x106 cells/kg to 5x106 cells/kg). Engrafment was observed for all patients and median time to neutrophiles (>0.5 G/l) and platelets (>50 G/l) recovery were respectively 19 and 12 days. Acute GVHD occurred for 5 patients whereas 3 patients developed chronic GVHD. At last follow-up, 4 patients died, 3 due to progressive disease, one due to hepatic GVHD. None of these 8 patients developed any clinical severe hemolysis, except one patient who presented a biological hemolysis with the development of a positive antiglobulin test 3 weeks after transplantation, without any consequences. Three months after transplant and at the last follow-up, the 4 long-term alive patients showed a stable erythropoietic reconstitution with an ABO-RhD donor determination. These data indicate that B-cell depletion is an efficient and safe method which could be used in case of minor ABO incompatibility.
- Published
- 2004
- Full Text
- View/download PDF
58. [Prenatal analysis of primary sulci by ultrasonography and MRI].
- Author
-
Quemener J, Bigot J, Joriot S, Devisme L, Bourgeot P, Debarge V, and Subtil D
- Subjects
- Cerebral Cortex abnormalities, Cerebral Cortex pathology, Female, Fetal Development, Gestational Age, Humans, Pregnancy, Cerebral Cortex embryology, Magnetic Resonance Imaging, Ultrasonography, Prenatal
- Abstract
Gyration abnormalities often reflect severe neurological diseases. Their diagnosis is impeded by our limited knowledge about normal sulci anatomy throughout fetal brain development. Primary sulci appears in a specific chronology which is unchanged among all fetuses. We think it is interesting to remind of sulci anatomy and then to depict sulci MRI and ultrasonography appearance at 22, 27 and 32 weeks of gestation. We pay particular attention to the lateral sulcus, also called Sylvian fissure., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
59. Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review.
- Author
-
Delhaes L, Ajzenberg D, Sicot B, Bourgeot P, Dardé ML, Dei-Cas E, and Houfflin-Debarge V
- Subjects
- Abortion, Induced, Adult, Coccidiostats therapeutic use, Female, Humans, Polymerase Chain Reaction, Pregnancy, Spiramycin therapeutic use, Toxoplasma isolation & purification, Toxoplasmosis, Congenital drug therapy, Ultrasonography, Genotype, Toxoplasma genetics, Toxoplasmosis, Congenital diagnostic imaging
- Published
- 2010
- Full Text
- View/download PDF
60. [Magnetic resonance imaging applications in obstetrics].
- Author
-
Launay S, Cuilleret V, Boyer C, Mestdagh P, Moisan S, Vaast P, Bourgeot P, Denes M, Rocourt N, and Robert Y
- Subjects
- Congenital Abnormalities diagnosis, Female, Fetal Diseases diagnosis, Humans, Pregnancy, Pregnancy Complications diagnosis, Magnetic Resonance Imaging, Prenatal Diagnosis methods
- Abstract
Purpose: To review the main indications and results of magnetic resonance imaging in the pregnant women., Material and Method: We reviewed MRI practice during the pregnancy based on our own experience in a prenatal diagnostic center and data in the literature. Rapid improvement in MRI technology has allowed more extensive use, giving a good contrast-to-noise ratio and multiplanar imaging., Results: Although ultrasound provides primary screening information, final diagnosis may require further investigations. MRI, to be performed in the second and third trimester, is the non-invasive second line tool of choice in this context. The most widespread indications are for brain disease: search for a cause of ventriculomegaly or biometric abnormality, confirmation of a malformative or acquired lesion. Progressively, indications were widened to head and neck, thorax, abdomen and pelvis areas. Moreover, systematic indications include previous fetal pathology or the pregnancy context. Other MRI indications have been suggested: placental malposition, pelvimetry and maternal genito-urinary tract., Conclusion: MRI is becoming the natural and necessary second line imaging technique, with increasing indications. It must be kept in mind however that all pathological conditions cannot be depicted by these morphological studies.
- Published
- 2003
61. [Trisomy 18: ultrasound aspects. Report of 40 cases].
- Author
-
Brun L, Dufour P, Savary JB, Valat AS, Boute O, Subtil D, Vaast P, Bourgeot P, Manouvrier S, de Martinville B, and Puech F
- Subjects
- Abnormalities, Multiple genetics, Adult, Female, Humans, Infant, Newborn, Male, Pregnancy, Pregnancy Trimester, First, Pregnancy Trimester, Second, Retrospective Studies, Trisomy diagnosis, Abnormalities, Multiple diagnostic imaging, Chromosomes, Human, Pair 18 genetics, Trisomy genetics, Ultrasonography, Prenatal
- Abstract
Objective: We describe the different ultrasound findings suggestive of trisomy 18., Patients and Methods: We conducted a retrospective study in 40 cases of trisomy 18 diagnosed in the department of obstetrics at the Lille University Hospital between 1988 and 1998., Results: Eighty percent of the women in this series were multiparous. Mean maternal age at discovery of the trisomy as 33.2 years and the mean gestational age was 20.4 weeks. Fifty-five percent of the cases were discovered during the second trimester of pregnancy, 22.5% during the third trimester and 22.5% during the first trimester. One ultrasound abnormality, at least, was detected in 36/40 cases (90%) a percentage that reached 96.8% taking into consideration the ultrasound examinations performed during the second and third trimesters (30/31 cases). The most frequently detected ultrasound abnormalities were: intra uterine growth retardation (IUGR: 50%), poly-hydramnios (42.5%), limb abnormalities (42.5%), cardiac defects (30%), facial abnormalities (37.5%), meningomyelocele (32.5%), digestive abnormalities (32.5%), urinary tract abnormalities (27.5%), lymphangiectasia and cystic hygroma (15%), and single umbilical artery (12.5%). Medical termination of pregnancy (TOP) was performed in 28 cases. There was one spontaneous miscarriage at 8 weeks and one in utero death (IUD) at 39 weeks in a patient who desired to continue her pregnancy. In 6 cases, the issue of the pregnancy was unknown because the patients were lost to follow-up. In 4 cases (10%), pregnancy was continued to delivery of live babies that only survived a few minutes to 7 days., Conclusion: The ultrasound signs suggestive of trisomy 18 change according to the term of pregnancy. At the first trimester, most of the signs are nonspecific, such as cystic hydroma or lymphangiectasia, and do not suggest the need for a karyotype. At the end of the second trimester, an association of various signs that alone would not be highly suspect suggest the need for further exploration in search of other signs: early IUGR, associated or not with poly-hydramnios, limb abnormalities, cardiac defects, omphalocele, diaphragmatic hernia, meningomyelocele, enlarged cisterna magna, choroid plexus cysts, single umbilical artery, facial dysmorphism, facial cleft, hydronephrosis.
- Published
- 2000
62. Echographic signs of trisomy 21 in the second trimester of pregnancy: actual value after analysis of the literature.
- Author
-
Vautier-Rit S, Subtil D, Vaast P, Dufour P, Valat AS, Bourgeot P, and Puech F
- Subjects
- Female, Femur diagnostic imaging, Femur embryology, Fingers diagnostic imaging, Fingers embryology, Humans, Humerus, Ilium diagnostic imaging, Ilium embryology, Neck diagnostic imaging, Neck embryology, Pregnancy, Pregnancy Trimester, Second, Down Syndrome diagnostic imaging, Ultrasonography, Prenatal
- Abstract
Objective: To evaluate the interest and to compare the major echographic signs of Down syndrome in the second trimester of pregnancy., Methods: A bibliographic research has been performed for most of the echographic signs known and studied until now. For each study and in average for each sign, we have computed its sensitivity, its specificity, its positive and negative predictive values using the results of the different authors. Then, we have compared the benefits/risk ratio for each of these signs: the number of Down syndrome cases detected versus healthy fetus lost due to amniocentesis complications., Results: The different signs can be ranked according to their benefits/risk ratio from top to bottom as follows: nuchal skinfold thickness, wide space between first and second toe, pyelectasis, large iliac angle, short humerus, short femur, hypoplasia of the middle phalanx of the fifth digit., Conclusion: These results suggest that second trimester echographic signs of Down syndrome must be evaluated as a function of the Down syndrome risk in the population under study. The presence of these signs does not always justify an amniocentesis; it should lead to a re-evaluation of the individual risk of a Down syndrome (a chart is given to guide this re-evaluation).
- Published
- 2000
63. [Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study].
- Author
-
Jemmali M, Valat AS, Poulain P, Favre R, Bourgeot P, Subtil D, and Puech F
- Subjects
- Facial Bones abnormalities, Female, Heart Defects, Congenital diagnosis, Humans, Karyotyping, Kidney abnormalities, Pregnancy, Prospective Studies, Trisomy, Chromosome Aberrations, Congenital Abnormalities diagnosis, Neck diagnostic imaging, Prenatal Diagnosis, Ultrasonography, Prenatal
- Abstract
Objective: To value the rate of chromosomal abnormalities and evolution of children who had a prenatal diagnosis of fetal nuchal translucency in the first trimester., Material and Methods: Multicenter prospective study conducted in 4,582 patients who had a first ultrasonography between 10 and 14 weeks' gestation (abdominal and/or transvaginal sonography). The measurement of fetal nuchal translucency was performed by mid-sagittal section and when it was higher than 2.5 mm a fetal karyotype was made., Results: Three hundred and fifty eight nuchal translucencies (> 2.5 mm) were diagnosed and 334 karyotypes were done. We found 25 chromosomal anomalies (7.4%): 14 trisomies 21; 7 trisomies 18; 2 trisomies 13; one triploidy and one trisomy X. The postnatal examination of children detected three congenital malformations (0.9%): one facial dysmorphia, one complex abnormal heart anatomy and one renal agenesia., Conclusion: Nuchal translucency (> 2.5 mm) is therefore a sonography sign associated with 7.4% of chromosomal anomalies. The distribution by size and mother ages is low. It should need superior larger-scale studies are needed for representative data. But this study shows that if fetal karyotype is normal, the incidence of congenital malformations seems to be the same by comparison with the general population.
- Published
- 1999
64. [Ultrasonographic signs of chromosome aberrations].
- Author
-
Dorin S, Dufour P, Valat AS, Subtil D, Vaast P, Bourgeot P, and Puech F
- Subjects
- Blood Flow Velocity, Chromosome Aberrations pathology, Chromosome Aberrations physiopathology, Chromosome Disorders, Female, Femur pathology, Humans, Neck pathology, Pregnancy, Pregnancy Trimester, First, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Umbilical Arteries, Chromosome Aberrations diagnostic imaging, Ultrasonography, Prenatal
- Abstract
We reviewed the literature on ultrasonographic criteria allowing prenatal diagnosis of chromosome aberrations, especially the most frequent: trisomy. Signs vary depending on the term of the ultrasound examination (first trimester ultrasound is often performed to early and several signs are observed in the second trimester). During the first trimester, the main criteria is the diagnosis of nuchal clearness 3 mm. The distance can only be measured with an appropriate sagittal CRL section by an experienced operator. The ideal term of this morphology ultrasound is 10 weeks gestation. During the second trimester, there are many suggestive criteria including non-specific signs: anomalous quantity of amniotic fluid, short femur, nuchal thickness 6 mm, isolated anomaly of the umbilical velocimetry, pyelectasy and fetal malformations (mainly cerebral or abdominal, including ophalocele and diaphragmatic hernia, anomalies, abnormal heart anatomy, cystic hygroma, facial anomalies and malformations of the members, often abnormal flexion of the hands).
- Published
- 1998
65. [Choroid plexus cysts and risks of chromosome anomalies. Review of the literature and proposed management].
- Author
-
Denis E, Dufour P, Valat AS, Vaast P, Subtil D, Bourgeot P, and Puech F
- Subjects
- Amniocentesis, Brain Diseases complications, Cysts complications, Humans, Incidence, Karyotyping, Brain Diseases diagnostic imaging, Choroid Plexus, Chromosomes, Human, Pair 18, Cysts diagnostic imaging, Trisomy, Ultrasonography, Prenatal
- Abstract
Objective: We propose to specify the different criteria of estimation and management in presence of a ultrasound discovery of a choroid plexus cyst., Method: A detailed review of the literature about this subject allowed to better apprehend the different attitudes taken up by the authors., Results: Fetal choroid plexus cysts (CPC) are potentially useful markers for trisomy 18 in as much as they are present in about 50% of affected fetuses and they are easily seen in the standard biparietal diameter view which is obtained for all routine ultrasound scans. However, advice is contradictory as to whether karyotyping should be proposed for all fetuses (1-2% of the population) where fetal CPC are diagnosed., Conclusion: The review of the literature show that the majority of the authors advocate amniocentesis when the CPC is associated with another ultrasound abnormality. Isolated, it imposes regular and meticulous morphologic ultrasound supervision to search for another possible associated ultrasound abnormality, if necessary, in a prenatal diagnosis center.
- Published
- 1998
66. [Prenatal diagnosis of three caudal regression syndromes associated with maternal diabetes].
- Author
-
Houfflin V, Subtil D, Cosson M, Valtille E, Carpentier F, Bourgeot P, Decocq J, Puech F, and Crepin G
- Subjects
- Adolescent, Adult, Congenital Abnormalities diagnostic imaging, Congenital Abnormalities etiology, Ectromelia diagnosis, Female, Humans, Pregnancy, Pregnancy in Diabetics prevention & control, Prognosis, Cauda Equina abnormalities, Pregnancy in Diabetics complications, Ultrasonography, Prenatal
- Abstract
We report three cases of caudal regression syndrome diagnosed in utero. Caudal regression syndrome (CRS) is a rare condition associating vertebral agenesia and urinary and digestive tract malformations. Pathogenesis is not clear but, as in our three cases, the CRS is often associated with poorly controlled maternal diabetes. Antenatal ultrasound examinations may reveal the disease in major forms with a non-viable foetus. In our 3 cases, a femoral "V" was associated with sudden interruption of the spine. Minor forms may not be recognized until childhood. Prognosis depends essentially on the extent of spinal involvement and associated malformations. Sirenomelus was considered for many years to be the most severe form of caudal regression, but recently acquired evidence suggests that these two conditions are separate entities.
- Published
- 1996
67. Prenatal diagnosis of metatropic dwarfism.
- Author
-
Manouvrier-Hanu S, Devisme L, Zelasko MC, Bourgeot P, Vincent-Delorme C, Valat-Rigot AS, Puech F, and Farriaux JP
- Subjects
- Adult, Bone Diseases, Developmental embryology, Bone and Bones diagnostic imaging, Bone and Bones embryology, Bone and Bones pathology, Cartilage pathology, Dwarfism embryology, Female, Humans, Male, Pregnancy, Radiography, Bone Diseases, Developmental diagnostic imaging, Dwarfism diagnostic imaging, Ultrasonography, Prenatal
- Abstract
We present a case of prenatal diagnosis of severe metatropic dysplasia at 20 weeks' gestation. The characteristic prenatal features of this rare autosomal recessive chondrodysplasia appear to be significant dwarfism with an enlarged head and a narrow thorax associated with enlargement of the hands and feet, and the radiographic 'dumb-bell' appearance of the long bones.
- Published
- 1995
- Full Text
- View/download PDF
68. [Non-immunologic hydrops fetalis and congenital chylothorax].
- Author
-
Dubos JP, Bouchez MC, Kacet N, Rouland V, Morisot C, and Bourgeot P
- Subjects
- Chylothorax complications, Female, Humans, Infant, Newborn, Pregnancy, Chylothorax congenital, Edema etiology, Fetal Diseases etiology
- Abstract
A child was born at the 37th week of pregnancy with hydrops fetalis. Hydramnios and hydrothorax had been proven by fetal ultrasonography. No fetal or maternal etiology was found. At age 4 days, at the beginning of enteral nutrition, the pleural effusion became characteristic of chylothorax. Recovery occurred after 2 weeks of parenteral nutrition. Chylothorax might be an unrecognized etiology of non immune hydrops fetalis. The relationships between both conditions and the interest of prenatal treatment are discussed.
- Published
- 1985
69. [Problem in echographic diagnosis: intrauterine pseudo-sac].
- Author
-
Bourgeot P, Fiadjoe M, Goeusse P, Puech F, Leroy JL, du Bois R, and Delecour M
- Subjects
- Diagnostic Errors, Female, Humans, Hypertrophy, Pregnancy, Uterus pathology, Pregnancy Tests, Pregnancy, Tubal diagnosis, Ultrasonography, Uterine Diseases diagnosis
- Abstract
The authors report eight cases of an intra-uterine pseudo-sac giving a wrong diagnosis of intra-uterine pregnancy. In two cases there was hypertrophy of the uterine mucosa and in six cases there was decidual change. The pseudo-sac corresponds to: either a blood clot held by the uterine mucosa; or a marked hypertrophy of the endometrium with intense decidualization and massive oedema. Certain characteristic criteria suggest that a pseudo-sac may be in the uterus; the oblong shape, dimensions which do not accord with the period of amenorrhoea, absence of peripheral and linear thickening, the variety of sites in which the picture is seen and in particular its disappearance, which makes it difficult to localise it in all sections. On the other hand it is not possible to diagnose between an intra-uterine pseudo-gestational sac and an early intra-uterine pregnancy which is not growing, in our present state of knowledge.
- Published
- 1982
70. [Echography of the corpus luteum].
- Author
-
Lemaire P, Bourgeot P, Puech F, Leroy JL, du Bois R, and Delecour M
- Subjects
- Corpus Luteum pathology, Female, Hemorrhage diagnosis, Humans, Ovarian Cysts diagnosis, Ovarian Follicle anatomy & histology, Corpus Luteum anatomy & histology, Ovarian Diseases diagnosis, Ultrasonography
- Abstract
The authors analyse the ultrasound aspects of normal and abnormal corpora lutea after reviewing the techniques for studying ovaries. The abnormalities include unruptured luteal follicles, cystic corpora lutea, haemorrhage into corpora lutea and ovarian hyperstimulation.
- Published
- 1985
71. [Neuro-cerebral malformation discovered during pregnancy and their treatment].
- Author
-
Bourgeot P, Delecour M, Leroy JL, and Puech F
- Subjects
- Female, Humans, Pregnancy, Brain abnormalities, Prenatal Diagnosis, Ultrasonography
- Published
- 1985
72. [Practical applications of ultrasonic fetal biometry].
- Author
-
Bourgeot P, Potier A, Goeusse P, Delecour M, Leroy JL, and Puech F
- Subjects
- Female, Fetal Diseases diagnosis, Fetus physiology, Humans, Pregnancy, Biometry, Fetal Monitoring methods, Ultrasonography
- Published
- 1979
73. [Obstetric outcome of the malformed uterus. Study of 155 pregnancies].
- Author
-
Lecoutour X, Bourgeot P, Segard C, Verbrackel L, Leroy JL, Puech F, and Delecour M
- Subjects
- Abortion, Spontaneous etiology, Cesarean Section, Dystocia etiology, Female, Fetal Death etiology, Humans, Infant Mortality, Infant, Newborn, Infant, Premature, Infertility, Female etiology, Obstetric Labor, Premature etiology, Pre-Eclampsia etiology, Pregnancy, Pregnancy Complications epidemiology, Pregnancy Complications etiology, Uterus abnormalities
- Abstract
Gynecological and obstetrical pathologies are considered in 155 pregnancies involving uterine deformity. Evaluation of their relative importance shows that maintenance of pregnancy is more important than pregnancy per se. Certain rules are proposed for treatment and obstetrical management of such pregnancies.
- Published
- 1986
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.